Davidson Matt 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Davidson Matt（CIK 1741937）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-06-16）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | 买入 | 61,647 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | 买入 | 3,427 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | 买入 | 232,417 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | 买入 | 1,822 | $0 |
| 2026-06-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Development Officer | 买入 | 101 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-16